Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series
Objective: Impetigo herpetiformis (IH) is a rare form of pustular psoriasis which may result in maternal and fetal morbidity and even mortality. Deficiency of interleukin-36 receptor antagonist (DITRA) is the most frequently identified genetic defect of IH. Currently there are no biologics approved...
Saved in:
Main Authors: | Chang-Yu Hsieh (Author), Yun-Ju Tsai (Author), Tsen-Fang Tsai (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Woronoff Ring in Deficiency of Interleukin-36 Receptor Antagonist (DITRA)
by: Daniel Morgado-Carasco, et al.
Published: (2019) -
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
by: Toni Hospach, et al.
Published: (2019) -
Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin
by: Edwin Cuperus, MD, et al.
Published: (2018) -
Treatment responses of four different biologics in a patient with recurrent generalized pustular psoriasis harboring IL36RN mutation
by: Chang-Yu Hsieh, et al.
Published: (2024) -
Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
by: Francisco Gómez-García, et al.
Published: (2018)